Mesenchymal Stem Cells (MSC) Derived from Induced Pluripotent Stem Cells (iPSC) Equivalent to Adipose‐Derived MSC in Promoting Intestinal Healing and Microbiome Normalization in Mouse Inflammatory Bowel Disease Model

Cellular therapy with allogeneic or autologous mesenchymal stem cells (MSC) has emerged as a promising new therapeutic strategy for managing inflammatory bowel disease (IBD). However, MSC therapy ideally requires a convenient and relatively homogenous cell source (typically bone marrow or adipose ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Soontararak, Sirikul, Chow, Lyndah, Johnson, Valerie, Coy, Jonathan, Wheat, William, Regan, Daniel, Dow, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Translational Research Articles and Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980202/
https://www.ncbi.nlm.nih.gov/pubmed/29635868
http://dx.doi.org/10.1002/sctm.17-0305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980202/
https://www.ncbi.nlm.nih.gov/pubmed/29635868
http://dx.doi.org/10.1002/sctm.17-0305

Ejemplares similares